Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Measuring progress on NCDs: one goal and five targets.

Beaglehole R, Bonita R, Horton R, Ezzati M, Bhala N, Amuyunzu-Nyamongo M, Mwatsama M, Reddy KS.

Lancet. 2012 Oct 13;380(9850):1283-5. doi: 10.1016/S0140-6736(12)61692-4. No abstract available.

PMID:
23063272
2.

Can noncommunicable diseases be prevented? Lessons from studies of populations and individuals.

Ezzati M, Riboli E.

Science. 2012 Sep 21;337(6101):1482-7. Review.

PMID:
22997325
3.

Management of NCD in low- and middle-income countries.

Checkley W, Ghannem H, Irazola V, Kimaiyo S, Levitt NS, Miranda JJ, Niessen L, Prabhakaran D, Rabadán-Diehl C, Ramirez-Zea M, Rubinstein A, Sigamani A, Smith R, Tandon N, Wu Y, Xavier D, Yan LL; GRAND South Network, UnitedHealth Group/National Heart, Lung, and Blood Institute Centers of Excellence.

Glob Heart. 2014 Dec;9(4):431-43. doi: 10.1016/j.gheart.2014.11.003. Review.

4.

The financial burden from non-communicable diseases in low- and middle-income countries: a literature review.

Kankeu HT, Saksena P, Xu K, Evans DB.

Health Res Policy Syst. 2013 Aug 16;11:31. doi: 10.1186/1478-4505-11-31. Review.

5.

Role of law at the non-communicable diseases-climate change interface: considerations for planetary and population health policy.

Boylan S, Syrett K, Colagiuri R.

Public Health. 2013 Jun;127(6):579-81. doi: 10.1016/j.puhe.2013.01.022. Epub 2013 Mar 13. Review. No abstract available.

PMID:
23497752
6.

The WHO global alliance against chronic respiratory diseases in Turkey (GARD Turkey).

Yorgancioğlu A, Türktaş H, Kalayci O, Yardim N, Buzgan T, Kocabaş A, Karlikaya C, Yildiz F, Ergün P, Mungan D, Kart L, Göktaş E, Musaonbaşioğlu S, Gündoğan A, Akdağ R, Akçay S, Akin M, Akkurt I, Altan P, Altunsu T, Arpaci N, Aydin C, Aydin S, Aydinli F, Aytaç B, Bavbek S, Biber C, Bingöl Karakoç G, Ceyhun G, Cakir B, Celik G, Cetinkaya T, Ciçek ME, Coban SC, Cobanoğlu N, Com S, Cöplü L, Demirkazik A, Doğan E, Ekmekçi EB, Elbir M, Erdoğan A, Ergüder T, Gemicioğlu B, Gögen S, Gülbahar O, Güngör H, Horzum E, Içer Y, Imamecioğlu AR, Kahraman N, Kakillioğlu T, Kalyoncu F, Karakaya M, Karakaya G, Karaodul G, Kesici C, Keskinkiliç B, Kilinç O, Kirmizitaş F, Kosdak M, Köktürk N, Metintaş M, Numanoğlu SC, Gümrükçüoğlu OF, Onal Z, Onal B, Ozacar R, Ozen HA, Ozkan S, Oztürk F, Polat H, Saçkesen C, Selçuk T, Serin G, Sönmez G, Sahin M, Sahinöz S, Sahinöz T, Simşek B, Tartan N, Toprak A, Tugay T, Tuncer A, Uçan ES, Unüvar N, Yapicikardeşler B, Yildirim N, Yol S, Yüksel H, Khaltaev N, Cruz A, Minelli E, Bateman E, Baena Cagnani C, Dahl R, Bousquet J.

Tuberk Toraks. 2009;57(4):439-52. Review.

PMID:
20037863
7.
8.

[WHO implementing national diabetes programs].

Baba S.

Nihon Rinsho. 2002 Jul;60 Suppl 7:83-93. Review. Japanese. No abstract available.

PMID:
12238135
9.

Policy initiatives, culture and the prevention and control of chronic non-communicable diseases (NCDs) in the Caribbean.

Samuels TA, Guell C, Legetic B, Unwin N.

Ethn Health. 2012;17(6):631-49. doi: 10.1080/13557858.2012.752072. Epub 2012 Dec 19. Review.

PMID:
23249261
10.

Cancer and the 'other' noncommunicable chronic diseases in older people living with HIV/AIDS in resource-limited settings: a challenge to success.

Hirschhorn LR, Kaaya SF, Garrity PS, Chopyak E, Fawzi MC.

AIDS. 2012 Jul 31;26 Suppl 1:S65-75. Review.

PMID:
22781178
11.

The role of the laboratory in the prevention and detection of chronic disease.

Schwartz MK.

Clin Chem. 1992 Aug;38(8B Pt 2):1539-46. Review.

PMID:
1643736
12.

[Chromium--essential trace element for prevention and treatment of diabetes mellitus and cardiovascular diseases].

Mirsky N.

Harefuah. 1997 Jan 15;132(2):133-6. Review. Hebrew. No abstract available.

PMID:
9119299
13.

[Non-communicable chronic diseases in Brazil: from risk factors to social impact].

Lessa I, Mendonça GA, Teixeira MT.

Bol Oficina Sanit Panam. 1996 May;120(5):389-413. Review. Portuguese.

PMID:
8924219
14.

A systematic review of school-based interventions to prevent risk factors associated with noncommunicable diseases.

Saraf DS, Nongkynrih B, Pandav CS, Gupta SK, Shah B, Kapoor SK, Krishnan A.

Asia Pac J Public Health. 2012 Sep;24(5):733-52. doi: 10.1177/1010539512445053. Epub 2012 May 16. Review.

PMID:
22593222
15.

[Operative complications of obese patients and its countermeasure].

Kawamura I.

Nihon Rinsho. 1995 Jun;53 Suppl:545-9. Review. Japanese. No abstract available.

PMID:
7563820
16.

Non-communicable diseases in low- and middle-income countries: context, determinants and health policy.

Miranda JJ, Kinra S, Casas JP, Davey Smith G, Ebrahim S.

Trop Med Int Health. 2008 Oct;13(10):1225-34. doi: 10.1111/j.1365-3156.2008.02116.x. Review.

17.

Health benefits of physical activity: the evidence.

Warburton DE, Nicol CW, Bredin SS.

CMAJ. 2006 Mar 14;174(6):801-9. Review.

18.

A decade of improvement in areas of chronic disease. Where do we go from here?

Rumm PD, Quenan L, Carty D, Taylor M.

WMJ. 2000 Jun;99(3):12-9. Review.

PMID:
10927975
19.

Urbanization and non-communicable disease in Southeast Asia: a review of current evidence.

Angkurawaranon C, Jiraporncharoen W, Chenthanakij B, Doyle P, Nitsch D.

Public Health. 2014 Oct;128(10):886-95. doi: 10.1016/j.puhe.2014.08.003. Epub 2014 Oct 13. Review.

PMID:
25369353
20.

Phaseolus beans: impact on glycaemic response and chronic disease risk in human subjects.

Hutchins AM, Winham DM, Thompson SV.

Br J Nutr. 2012 Aug;108 Suppl 1:S52-65. doi: 10.1017/S0007114512000761. Review.

PMID:
22916816
Items per page

Supplemental Content

Write to the Help Desk